NCT01445535 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Date treatment consent signed until 30 days after removal from study treatment or until off study, whichever comes first, approximately 22 weeks.
- Other-event reporting threshold
- 0%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Cohort 1 - 3.4 mg/kg | 0 / 3 | 3 / 3 | 2 / 3 |
| Cohort 2 - 4.8 mg/kg | 2 / 3 | 3 / 3 | 3 / 3 |
| Cohort 3 - 8.5 mg/kg | 2 / 3 | 3 / 3 | 3 / 3 |
| Cohort 4 - 15 mg/kg | 1 / 6 | 5 / 6 | 4 / 6 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- (documented clinically or microbiologically) with Grade 3 or 4 neutrophils (ANC \<1.0 x 10e9/L)::Blood
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- (fever of unknown origin without clinically or microbiologically documented infection)(ANC \<1.0 x 10e9/L, fever \>=38.5 degrees C)
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Fracture
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 3
- term
- Alkaline phosphatase
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Immune system disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Bilirubin (hyperbilirubinemia)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Calcium, serum-low (hypocalcemia)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 3
- num Events
- 4
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 6
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 4
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Dry skin
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Extrapyramidal/involuntary movement/restlessness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 6
- num Events
- 5
- term
- Fatigue (asthenia, lethargy, malaise)
Complete source fields
- event Groups
- deaths Num Affected
- 2
- deaths Num At Risk
- 3
- description
- 3.4 mg/kg siplizumab was given on day 1 of each cycle followed by etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH) (combo chemo) on days 1-5 for 21 days.
- id
- EG000
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 0
- serious Num At Risk
- 3
- title
- Cohort 1 - 3.4 mg/kg
- deaths Num Affected
- 3
- deaths Num At Risk
- 3
- description
- 4.8 mg/kg siplizumab was given on day 1 of each cycle followed by etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH) (combo chemo) on days 1-5 for 21 days.
- id
- EG001
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 2
- serious Num At Risk
- 3
- title
- Cohort 2 - 4.8 mg/kg
- deaths Num Affected
- 3
- deaths Num At Risk
- 3
- description
- 8.5 mg/kg siplizumab was given on day 1 of each cycle followed by etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH) (combo chemo) on days 1-5 for 21 days.
- id
- EG002
- other Num Affected
- 3
- other Num At Risk
- 3
- serious Num Affected
- 2
- serious Num At Risk
- 3
- title
- Cohort 3 - 8.5 mg/kg
- deaths Num Affected
- 4
- deaths Num At Risk
- 6
- description
- 15 mg/kg siplizumab was given on day 1 of each cycle followed by etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH) (combo chemo) on days 1-5 for 21 days.
- id
- EG003
- other Num Affected
- 5
- other Num At Risk
- 6
- serious Num Affected
- 1
- serious Num At Risk
- 6
- title
- Cohort 4 - 15 mg/kg
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 3
- term
- Alkaline phosphatase
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Immune system disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Anorexia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Bilirubin (hyperbilirubinemia)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Calcium, serum-low (hypocalcemia)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 3
- num Events
- 4
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 6
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Cough
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 6
- num Events
- 2
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 3
- num At Risk
- 6
- num Events
- 4
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Dry skin
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Extrapyramidal/involuntary movement/restlessness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 3
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG003
- num Affected
- 5
- num At Risk
- 6
- num Events
- 5
- term
- Fatigue (asthenia, lethargy, malaise)
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- (documented clinically or microbiologically) with Grade 3 or 4 neutrophils (ANC \<1.0 x 10e9/L)::Blood
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 3
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- (fever of unknown origin without clinically or microbiologically documented infection)(ANC \<1.0 x 10e9/L, fever \>=38.5 degrees C)
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 3
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- CTCAE 3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 3
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- term
- Fracture
- time Frame
- Date treatment consent signed until 30 days after removal from study treatment or until off study, whichever comes first, approximately 22 weeks.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle